Jonathan Frederick Head serves as Executive at OncBioMune Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Jonathan Frederick Head has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 7, 2020 involved receiving (via award) 166,667 shares valued at $10.0K.
Jonathan Frederick Head currently holds 189,236 shares of OncBioMune Pharmaceuticals, Inc (OBMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Frederick Head has been a net neutral trader of OBMP stock. They have purchased $0 and sold $0 worth of shares.
Jonathan Frederick Head's most recent insider trade was on May 7, 2020, when they sold 166,667 shares at $0.06 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 10, 2017 | OBMP | $0 | Other | 2,892,000 | $N/A | Discretionary |
| Sep 2, 2015 | OBMP | $0 | Award | 500,000 | $N/A | Discretionary |
| Sep 2, 2015 | OBMP | $0 | Award | 17,951,078 | $N/A | Discretionary |
| Sep 2, 2015 | OBMP | $0 | Sale | 1,025,000 | $N/A | Discretionary |